In both colon cancer cell lines, treatment with the anti-neoplastic drugs decreased significantly methylation of the CAV1 promoter region (Figure 4), which likely explains, at least in part, the increase in CAV1 mRNA (Figure 3) and protein (Figure 2) levels observed following drug exposure. Here, CAV1 is linked to malignant colon neoplasm.